PPI regulation under the microscope

Proton pump inhibitors (PPIs) are very effective and suitable for certain indications and treatment periods, but there is an increasing trend towards “off-label” prescriptions. To ensure that temporary administration for a specific indication does not become an unreflected permanent medication, North American experts have summarized ten best practice recommendations to help decide whether discontinuation (“deprescribing”) of PPIs could be an option to consider.